PHARMACODYNAMIC EFFECTS OF ADJUNCTIVE CLOPIDOGREL THERAPY IN PATIENTS WITH ATHEROSCLEROTIC DISEASE ON DUAL PATHWAY INHIBITION WITH ASPIRIN AND LOW-DOSE RIVAROXABAN

Authors :: Martin Zenni
Siva Suryadevara
Fabiana Rollini
Dominick J. Angiolillo
Naji Maaliki
Latonya F. Been
Sida Jia
Patrick Abou Jaoude
Andrea Rivas
Xuan Zhou
Andres Pineda Maldonado
Francesco Franchi
Lisa K. Jennings
Daniel Soffer
Theodore A. Bass
Chang Hoon Lee
Source :: Journal of the American College of Cardiology. 77:1187
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Rivaroxaban
Aspirin
business.industry
Low dose
Atherosclerotic disease
Pharmacology
Clopidogrel
Pharmacodynamics
Medicine
In patient
Cardiology and Cardiovascular Medicine
business
Dual pathway
medicine.drug

Full Text Access

Tools